Postpartum hemorrhage (PPH) is a potentially life-threatening condition, which needs
multidisciplinary management. Uterine atony represents up to 80% of all causes of PPH …

Postpartum hemorrhage (PPH) is a life-threatening condition and remains a leading cause
of maternal mortality. Transcatheter arterial embolization (TAE) is an effective therapeutic …

Purpose To assess the safety and efficacy of transcatheter arterial embolization (TAE) for the
management of secondary postpartum hemorrhage (PPH) and to determine the factors …

Background: Transcatheter arterial embolization (TAE) is considered a safe, life-saving
procedure in postpartum hemorrhage (PPH), but its long-term effect on menstruation and …

Transcatheter arterial embolization is a minimally invasive intervention developed from
diagnostic angiography. The evolution of endovascular techniques, including arterial …

Postpartum hemorrhage remains a major cause of morbidity and mortality for the obstetric
patient. A timely, stepwise approach to management can reduce the negative impact of this …

Postpartum hemorrhage (PPH) is a common source of morbidity and mortality for delivering
mothers worldwide, resulting in greater than 100,000 deaths per annum. Pathologic …

Background Transarterial embolisation (TAE) has been attracting attention as a treatment
option for post‐partum haemorrhage (PPH). Aims We investigated cases in which TAE was …

Postpartum hemorrhage (PPH) is the leading cause of maternal perinatal morbidity and
mortality worldwide. Defined as greater than 500 mL blood loss after vaginal delivery, and …

PURPOSE: To evaluate the efficacy and safety of arterial embolization (AE) for treatment of
primary postpartum hemorrhage (PPH), and the factors associated with clinical success …